Ancora Advisors’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.53K | Buy |
500
+300
| +150% | +$2.88K | ﹤0.01% | 1996 |
|
|
2025
Q4 | $1.93K | Sell |
200
-1,350
| -87% | -$12.7K | ﹤0.01% | 2139 |
|
|
2025
Q3 | $14.1K | Hold |
1,550
| – | – | ﹤0.01% | 1317 |
|
|
2025
Q2 | $14.6K | Sell |
1,550
-2,600
| -63% | -$24.8K | ﹤0.01% | 1303 |
|
|
2025
Q1 | $41.8K | Sell |
4,150
-1,000
| -19% | -$10K | ﹤0.01% | 1043 |
|
|
2024
Q4 | $49.6K | Buy |
5,150
+500
| +11% | +$5.18K | ﹤0.01% | 1005 |
|
|
2024
Q3 | $50.9K | Hold |
4,650
| – | – | ﹤0.01% | 985 |
|
|
2024
Q2 | $44.5K | Sell |
4,650
-1,000
| -18% | -$9.63K | ﹤0.01% | 972 |
|
|
2024
Q1 | $57.9K | Hold |
5,650
| – | – | ﹤0.01% | 927 |
|
|
2023
Q4 | $52.7K | Hold |
5,650
| – | – | ﹤0.01% | 933 |
|
|
2023
Q3 | $48.5K | Hold |
5,650
| – | – | ﹤0.01% | 916 |
|
|
2023
Q2 | $56.3K | Hold |
5,650
| – | – | ﹤0.01% | 886 |
|
|
2023
Q1 | $57K | Sell |
5,650
-500
| -8% | -$5.08K | ﹤0.01% | 882 |
|
|
2022
Q4 | $63K | Hold |
6,150
| – | – | ﹤0.01% | 917 |
|
|
2022
Q3 | $58K | Hold |
6,150
| – | – | ﹤0.01% | 1038 |
|
|
2022
Q2 | $66K | Hold |
6,150
| – | – | ﹤0.01% | 1085 |
|
|
2022
Q1 | $79K | Sell |
6,150
-240
| -4% | -$3.06K | ﹤0.01% | 1099 |
|
|
2021
Q4 | $87K | Hold |
6,390
| – | – | ﹤0.01% | 1079 |
|
|
2021
Q3 | $84K | Hold |
6,390
| – | – | ﹤0.01% | 1025 |
|
|
2021
Q2 | $86K | Sell |
6,390
-500
| -7% | -$6.57K | ﹤0.01% | 949 |
|
|
2021
Q1 | $86K | Sell |
6,890
-21,534
| -76% | -$264K | ﹤0.01% | 923 |
|
|
2020
Q4 | $340K | Hold |
28,424
| – | – | 0.01% | 534 |
|
|
2020
Q3 | $293K | Hold |
28,424
| – | – | 0.01% | 537 |
|
|
2020
Q2 | $285K | Sell |
28,424
-450
| -2% | -$4.46K | 0.01% | 542 |
|
|
2020
Q1 | $250K | Sell |
28,874
-5,000
| -15% | -$53K | 0.01% | 598 |
|
|
2019
Q4 | $390K | Sell |
33,874
-500
| -1% | -$5.4K | 0.01% | 540 |
|
|
2019
Q3 | $358K | Hold |
34,374
| – | – | 0.02% | 509 |
|
|
2019
Q2 | $362K | Sell |
34,374
-32,700
| -49% | -$343K | 0.02% | 476 |
|
|
2019
Q1 | $705K | Sell |
67,074
-23,000
| -26% | -$233K | 0.03% | 359 |
|
|
2018
Q4 | $833K | Sell |
90,074
-33,566
| -27% | -$345K | 0.04% | 318 |
|
|
2018
Q3 | $1.36M | Sell |
123,640
-23,325
| -16% | -$248K | 0.05% | 301 |
|
|
2018
Q2 | $1.47M | Sell |
146,965
-17,782
| -11% | -$173K | 0.06% | 272 |
|
|
2018
Q1 | $1.56M | Sell |
164,747
-571
| -0.3% | -$5.8K | 0.07% | 261 |
|
|
2017
Q4 | $1.71M | Buy |
165,318
+10,231
| +7% | +$102K | 0.09% | 224 |
|
|
2017
Q3 | $1.57M | Buy |
155,087
+6,806
| +5% | +$70.8K | 0.09% | 242 |
|
|
2017
Q2 | $1.61M | Buy |
148,281
+6,825
| +5% | +$71K | 0.1% | 232 |
|
|
2017
Q1 | $1.41M | Buy |
141,456
+71,318
| +102% | +$708K | 0.1% | 250 |
|
|
2016
Q4 | $662K | Buy |
+70,138
| New | +$683K | 0.05% | 359 |
|
Other funds holding GRX
SCM
SIA
GI
BBPWM
EPW
ACP
SI
Ancora Advisors's GRX Position: Q1 2026 in Review
Ancora Advisors increased its Gabelli Healthcare & Wellness Trust (GRX) stake by 150% in Q1 2026, buying an estimated $2.88K and bringing the position to 500 shares worth $4.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.
Ancora Advisors first reported a position in GRX in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.71M in Q4 2017. 51 funds tracked by Wall St. Rank hold GRX as of Q1 2026.
- Ancora Advisors held 500 shares of Gabelli Healthcare & Wellness Trust worth $4.53K as of Q1 2026.
- Ancora Advisors bought 300 Gabelli Healthcare & Wellness Trust shares in Q1 2026, an estimated $2.88K.
- Gabelli Healthcare & Wellness Trust made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1996 holding.
- Ancora Advisors first reported a position in Gabelli Healthcare & Wellness Trust in Q4 2016 and has held it in 38 quarters since.
- Ancora Advisors's Gabelli Healthcare & Wellness Trust position peaked at $1.71M in Q4 2017.
- 51 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.